Insight, analysis & opinion from Joe Paduda
The FDA announced today that Pfizer’s Celebrex significantly increases the risk of cardiovascular problems. What does this have to do with Workers’ Comp? A lot. Celebrex, approved by the FDA for treatment of arthritis, has been one of the most … Continue reading Celebrex – another WC liability?
Read More...A very good discussion of the contentious relationship between (and among) hospitals, employers, and insurers can be found on healthsignals new york. The article refers to recent developments in the Denver market that are worth reflecting upon.
Read More...Weiss Ratings has recently released their report on insurance industry profitability, and the news is both good and bad. Good if you compare it to past year’s reports, bad if you are expecting robust returns. The report notes: “Of the … Continue reading Insurance Industry Profit Margins
Read More...I live in Madison, Conn., a town of some 18,000 located between New Haven and Old Saybrook on the Connecticut shoreline. Madison is a pretty well-off place; schools are excellent, services good, and government responsive. To fulfill my civic responsibility, … Continue reading The impact of health care costs in small town USA
Read More...Tom Lynch’s “Workers’ Comp Insider” blog provides interesting news related to return to work, safety and risk management among other topics. The latest post is a synopsis of state-specific WC news. A good site to bookmark and check frequently; the … Continue reading Interesting item on state WC issues
Read More...